Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Clin J Pain. 2019 Nov;35(11):869–879. doi: 10.1097/AJP.0000000000000755

Table1:

Participant characteristics

HC (n = 22) Mean ± SD FM negative (n = 24) Mean ± SD FM positive (n = 22) Mean ± SD P value (t test)! P value (ANOVA)
Age (years) 41.15 ± 8.830 42.38 ± 12.37 43.95 ± 14.00 0.687 0.788
Gender (% Female) 68% 63% 77% 0.277 0.552
BMI 28.35 ± 8.10 28.76 ± 6.20 31.34 ± 6.13 0.163 0.296
Race     0.576 0.316
White 68.00% 66.70% 72.70%  
Black 5% 16.70% 13.70%  
Asian 18.00% 4.20% 0.00%  
More than one race 9.00% 0.00% 4.55%  
Other 0.00% 0.00% 4.55%  
Pain average (NRS) ----------- 4.13 ± 1.12 5.27 ± 1.49 < 0.01*
Pain duration (months) ----------- 75.04 ± 104.87 135.09 ± 171.12 0.155
number of pain locations ----------- 4.50 ± 1.79 9.77 ± 3.84 < 0.001*
Opioid use (%Yes) ----------- 0% 36% < 0.001*

FM: Fibromyalgia

HC: Healthy controls

BMI: Body mass index, NRS: Numeric rating scale

!:

Comparisons of FM negative CLBP participants and FM negative CLBP participants